Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • AV Rheum
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • AV Rheum
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS
EditorialEditorial

Diabetogenesis in Rheumatoid Arthritis: Do Inflammation and Glucocorticoid-induced Incretin Overproduction Cause β-Cell Overcompensation and Consequent Premature Decompensation?

PATRICK H. DESSEIN, ANNE E. STANWIX and AHMED SOLOMON
The Journal of Rheumatology March 2019, 46 (3) 219-222; DOI: https://doi.org/10.3899/jrheum.181163
PATRICK H. DESSEIN
Cardiovascular Pathophysiology, and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, and Department of Rheumatology, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, and Free University and University Hospital, Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for PATRICK H. DESSEIN
  • For correspondence: patrick.dessein22@gmail.com
ANNE E. STANWIX
Department of Rheumatology, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AHMED SOLOMON
Department of Rheumatology, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Dessein PH,
    2. Solomon A,
    3. Hollan I
    . Metabolic abnormalities in patients with inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 2016;30:901–15.
    OpenUrl
  2. 2.↵
    1. Bayer JF,
    2. Gourraud PA,
    3. Cantagrel A,
    4. Davignon JL,
    5. Constantin A
    . Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 2011;78:179–83.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Baghdadi LR,
    2. Woodman RJ,
    3. Shanahan EM,
    4. Mangoni A
    . The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One 2015;10:e0117952.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Ruscitti P,
    2. Ursini F,
    3. Cipriani P,
    4. Liakouli V,
    5. Carubbi F,
    6. Berardicurti O,
    7. et al.
    Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year single-centre, longitudinal study. PLoS One 2017;12:e0181203.
    OpenUrl
  5. 5.↵
    1. Lewis GF,
    2. Carpentier A,
    3. Adeli K,
    4. Giacca A
    . Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Reviews 2002;23:201–29.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Dessein PH,
    2. Joffe BI,
    3. Stanwix AE
    . Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis. J Rheumatol 2003;30:1403–5.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Kahn SE,
    2. Prigeon RL,
    3. Schwarts RS,
    4. Fujimoto WY,
    5. Knopp RH,
    6. Brunzell JD,
    7. et al.
    Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. J Nutr 2001;131:354S–360S.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Meier JJ,
    2. Veldhuis JD,
    3. Butler PC
    . Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes 2005;54:1649–58.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Cersosimo E,
    2. Solis-Herrera C,
    3. Trautman ME,
    4. Malloy J,
    5. Triplitt CL
    . Assessment of pancreatic β-cell function: review of methods and clinical applications. Curr Diabetes Rev 2014;10:2–42.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Nicolau J,
    2. Lequerre T,
    3. Bacquet H,
    4. Vittecoq O
    . Rheumatoid arthritis, insulin resistance, and diabetes. Joint Spine Bone 2017;84:411–6.
    OpenUrl
  11. 11.↵
    1. Dessein PH,
    2. Joffe BI
    . Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006;54:2765–75.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Dessein PH,
    2. Joffe BI,
    3. Stanwix AE
    . Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 2004;14:443–6.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Ferraz-Amaro I,
    2. Garcia-Dopico JA,
    3. Medina-Vega L,
    4. Gonzalez-Gay MA,
    5. Diaz-Gonzalez F
    . Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients. Arthritis Res Ther 2013;15:R17.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Stagakis I,
    2. Bersias G,
    3. Karvounaris S,
    4. Kavousanaki M,
    5. Virla D,
    6. Raptopoulou A,
    7. et al.
    Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance. Arthritis Res Ther 2012;14:R141.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Wasko MC,
    2. McClure CK,
    3. Kelsey SF,
    4. Huber K,
    5. Orchard T,
    6. Toledo FG
    . Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial. Diabetologia 2015;58:2336–43.
    OpenUrl
  16. 16.↵
    1. Tejera-Segura B,
    2. Lopez-Mejias R,
    3. de Vera-Gonzalez AM,
    4. Jiménez-Sosa A,
    5. Olmos JM,
    6. Hernández JL,
    7. et al.
    Relationship between insulin sensitivity and β-cell secretion in nondiabetic subjects with rheumatoid arthritis. J Rheumatol 2019;46:229–36.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Tejera-Segura B,
    2. López-Mejías R,
    3. Dominguez-Luis MJ,
    4. de Vera-González AM,
    5. González-Delgado A,
    6. Ubilla B,
    7. et al.
    Incretins in patients with rheumatoid arthritis. Arthritis Res Ther 2017;19:229.
    OpenUrl
  18. 18.↵
    1. Kim W,
    2. Egan JM
    . The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008;60:470–512.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Gower BA,
    2. Granger WM,
    3. Franklin F,
    4. Shechuk RM,
    5. Goran MI
    . Contribution of insulin secretion and clearance to glucose-induced insulin concentrations in African-American and Caucasian children. J Clin Endocrinol Metab 2002;87:2218–24.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Hoes JN,
    2. van der Goes MC,
    3. van Raalte DH,
    4. van der Zijl NJ,
    5. den Uyl D,
    6. Lems WF,
    7. et al.
    Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids. Ann Rheum Dis 2011;70:1887–94.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 46, Issue 3
1 Mar 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diabetogenesis in Rheumatoid Arthritis: Do Inflammation and Glucocorticoid-induced Incretin Overproduction Cause β-Cell Overcompensation and Consequent Premature Decompensation?
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
Citation Tools
Diabetogenesis in Rheumatoid Arthritis: Do Inflammation and Glucocorticoid-induced Incretin Overproduction Cause β-Cell Overcompensation and Consequent Premature Decompensation?
PATRICK H. DESSEIN, ANNE E. STANWIX, AHMED SOLOMON
The Journal of Rheumatology Mar 2019, 46 (3) 219-222; DOI: 10.3899/jrheum.181163

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Diabetogenesis in Rheumatoid Arthritis: Do Inflammation and Glucocorticoid-induced Incretin Overproduction Cause β-Cell Overcompensation and Consequent Premature Decompensation?
PATRICK H. DESSEIN, ANNE E. STANWIX, AHMED SOLOMON
The Journal of Rheumatology Mar 2019, 46 (3) 219-222; DOI: 10.3899/jrheum.181163
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Save to my folders

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Toward the Estimation of Unbiased Disease Prevalence Estimates Using Administrative Health Records
  • Musculotendinous Inflammation: The Defining Pathology of Polymyalgia Rheumatica?
  • Psoriatic Arthritis, Psoriatic Disease, or Psoriatic Syndrome?
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • AV Rheum

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire